ArticlePsoriasis (Auckland, N.Z.)2025

Treatment of Psoriasis with II-17 Inhibitors: Comparison of Long-Term Effectiveness and Drug Survival of Secukinumab vs Ixekizumab in Real-World Practice.

Joan Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.